Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFL-assisted MAL-PDT for Actinic Keratosis
NCT02248298Phase 1Completed
- Sponsor
- Dong-A University
- Start
- Jan 2012
- Primary completion
- Jun 2014
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of methyl aminolevulinate in actinic keratosis (AK), sponsored by Dong-A University. Started Jan 2012; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02248298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248298.